161 related articles for article (PubMed ID: 35149705)
21. Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines.
Dubeykovskaya Z; Dubeykovskiy A; Solal-Cohen J; Wang TC
J Biol Chem; 2009 Feb; 284(6):3650-62. PubMed ID: 19064997
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
23. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment.
Skroblyn T; Joedicke JJ; Pfau M; Krüger K; Bourquin JP; Izraeli S; Eckert C; Höpken UE
J Pathol; 2022 Sep; 258(1):12-25. PubMed ID: 35522562
[TBL] [Abstract][Full Text] [Related]
25. ZAP-70 as a possible prognostic factor in childhood acute lymphoblastic leukemia.
Ebeid E; Kamel M; Moussa H; Galal U
J Egypt Natl Canc Inst; 2008 Jun; 20(2):121-6. PubMed ID: 20029467
[TBL] [Abstract][Full Text] [Related]
26. POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL.
Sison EA; Magoon D; Li L; Annesley CE; Romagnoli B; Douglas GJ; Tuffin G; Zimmermann J; Brown P
Oncotarget; 2015 Oct; 6(31):30902-18. PubMed ID: 26360610
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
28. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
Peled A; Klein S; Beider K; Burger JA; Abraham M
Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
[TBL] [Abstract][Full Text] [Related]
29. [Significance of CXCL12/CXCR4 expression in T-lymphoblastic lymphoma/leukemia].
Yu ZZ; Xi YF; Li J; Bai WQ; Gao N; Bu P
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):838-843. PubMed ID: 28056298
[No Abstract] [Full Text] [Related]
30. Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
Ferrandino F; Bernardini G; Tsaouli G; Grazioli P; Campese AF; Noce C; Ciuffetta A; Vacca A; Besharat ZM; Bellavia D; Screpanti I; Felli MP
Oncogene; 2018 Dec; 37(49):6285-6298. PubMed ID: 30038265
[TBL] [Abstract][Full Text] [Related]
31. Tumor-Secreted GRP78 Promotes the Establishment of a Pre-metastatic Niche in the Liver Microenvironment.
Chen L; Zheng H; Yu X; Liu L; Li H; Zhu H; Zhang Z; Lei P; Shen G
Front Immunol; 2020; 11():584458. PubMed ID: 33133103
[TBL] [Abstract][Full Text] [Related]
32. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
[TBL] [Abstract][Full Text] [Related]
33. CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK.
Juarez JG; Thien M; Dela Pena A; Baraz R; Bradstock KF; Bendall LJ
Br J Haematol; 2009 May; 145(4):491-9. PubMed ID: 19344405
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
35. Cell surface GRP78 promotes stemness in normal and neoplastic cells.
Conner C; Lager TW; Guldner IH; Wu MZ; Hishida Y; Hishida T; Ruiz S; Yamasaki AE; Gilson RC; Belmonte JCI; Gray PC; Kelber JA; Zhang S; Panopoulos AD
Sci Rep; 2020 Feb; 10(1):3474. PubMed ID: 32103065
[TBL] [Abstract][Full Text] [Related]
36. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
37. The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system.
Alsadeq A; Fedders H; Vokuhl C; Belau NM; Zimmermann M; Wirbelauer T; Spielberg S; Vossen-Gajcy M; Cario G; Schrappe M; Schewe DM
Haematologica; 2017 Feb; 102(2):346-355. PubMed ID: 27686375
[TBL] [Abstract][Full Text] [Related]
38. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
39. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse.
Velázquez-Avila M; Balandrán JC; Ramírez-Ramírez D; Velázquez-Avila M; Sandoval A; Felipe-López A; Nava P; Alvarado-Moreno JA; Dozal D; Prieto-Chávez JL; Schaks M; Rottner K; Dorantes-Acosta E; López-Martínez B; Schnoor M; Pelayo R
Leukemia; 2019 Jun; 33(6):1337-1348. PubMed ID: 30573781
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow recovery of hematopoietic stem cells and microenvironment after chemotherapy in childhood acute lymphoblastic leukemia: consecutive observations according to chemotherapy schedule.
Park SH; Lee MJ; Park CJ; Jang S; Seo EJ; Im HJ; Seo JJ
Pediatr Hematol Oncol; 2019 May; 36(4):222-235. PubMed ID: 31313940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
